Feb 19, 2024
Dr. Shuba Iyengar, Co-Founder and Chief Medical Officer of Allermi, is focused on providing better care and access to allergy treatments. Allermi has developed a personalized approach to diagnosing allergies and personalizing nasal spray formulations to provide a more precise solution to those suffering from nasal congestion, coughing, sinus pain, and itchy eyes. While there are seasonal allergies, doctors are seeing an increase in allergies related to climate change, pollution, and other changes in the environment.
Shuba explains, "We want to make sure that everyone knows that allergies are a chronic problem and affect your everyday life. I have allergies, so I completely sympathize with people who have bad allergies. But when you get allergies, what's happening is the inside of your nose is getting a little bit swollen. But to some extent, in the beginning, you can kind of compensate. You can get by. So, if you can't breathe to one side, you'll breathe through the other. If you can't breathe through the side, you'll start to mouth breathe."
"As allergists and even general doctors, the toolbox we have to treat allergies is okay but not great for everyone. A lot of times, if they can see their doctor, people might get a prescription nasal spray or be advised to take an oral antihistamine or an allergy pill. They might go to the drugstore and try to buy an over-the-counter nasal spray like Flonase or Nasacort. And for a lot of people, these medicines don't quite work as well or not enough."
#Allermi #Allergies #AllergyCare #Telehealth
